Health ❯ Public Health ❯ Disease Prevention

HIV

Lenacapavir PrEP Testing Testing Programs STDs Pre-exposure Prophylaxis Medical Advances Cabotegravir Prevention Strategies Infection Control

Model Projects 10% Rise in U.S. HIV Infections if CDC Testing Funds End

Researchers warn that cuts to CDC-backed testing could reverse recent gains in HIV control.

NHS to Roll Out First Long‑Acting HIV Prevention Injection After NICE Green Light

Cofepris Authorizes Bi-Monthly Injectable PrEP in Mexico

Autopsy Begins for Italian Harrods Merchandiser Found Dead in London

EU Backs First Twice-Yearly Injectable for HIV Prevention

WHO Endorses Twice-Yearly HIV Prevention Jab as Early Adopters Plan 2026 Rollout

WHO Recommends Six-Monthly Lenacapavir Injection for HIV Prevention

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

UK Pledges £27 Million to Expand A&E HIV Testing Programme

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV